Symptomtext
Had a high stage fever at 103.5 and dropped after an hour; This is a spontaneous report from a contactable other healthcare professional, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8448) via an intramuscular route of administration in the left arm on 20Aug2021 at 17:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included unspecified anti-depressants medication and levonorgestrel (MIRENA) intrauterine device; both for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 21Aug2021 at 17:30, the patient had a high stage fever at 103.5 and dropped after an hour. On the same day, the patient underwent body temperature test and the result was found to be 103.5 (unspecified units). The event high stage fever at 103.5 did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event high stage fever at 103.5 and dropped after an hour was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.